ArticleEndocrinology and metabolism (Seoul, Korea)2021

Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway.

Jun-Qing Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.